Kapil Saxena Selected Research

Kapil Saxena Research Topics

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2020
3	Infections 01/2019 - 01/2016
2	Hemophilia A (Haemophilia) 07/2013 - 01/2013
2	Hemorrhage 07/2013 - 01/2013
1	Neutropenia 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neoplasms (Cancer) 10/2021
1	Blast Crisis (Blast Phase) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Disease Progression 01/2021
1	Virus Diseases (Viral Diseases) 01/2017
1	Diarrhea 01/2016
1	GATA2 Deficiency 12/2014
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2014
1	Papillomavirus Infections 12/2014
1	Thrombosis (Thrombus) 07/2013
1	Autoimmune Diseases (Autoimmune Disease) 04/2009
1	Peripheral Nerve Injuries 12/2007

2	trastuzumab deruxtecanIBA 01/2022 - 01/2021
2	Attenuated VaccinesIBA 01/2019 - 01/2016
2	Factor VIII (Coagulation Factor VIII)IBA 07/2013 - 01/2013
1	human ERBB2 proteinIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	venetoclaxIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2021
1	avelumabIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	InterferonsIBA 01/2017
1	Interferon LambdaIBA 01/2017
1	Enterotoxins (Enterotoxin)IBA 01/2016
1	recombinant FVIIa (rFVIIa)FDA Link 07/2013
1	HLA-DRB1*03:01 antigenIBA 04/2009
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2007